文献速递炎症性肠病消化内镜

新冠疫情期间炎症性肠病服务的使用与结局:一项全国性观察性研究

The use of, and outcomes for, inflammatory bowel disease services during the Covid-19 pandemic: a nationwide observational study.
PubMed 文献 · Aliment Pharmacol Ther · 2022-02-07

该全国性观察性研究利用英格兰2015至2020年行政数据,比较疫情前与疫情期间急诊炎症性肠病(IBD)住院及操作量。疫情期间急性溃疡性结肠炎和急性克罗恩病就诊量分别下降16.4%和8.7%,内镜检查减少17544例(35.2%),30天死亡率无显著差异,急性UC的28天急诊再入院率升高(14.1% vs 13.4%,P=0.012)。

要点

  • 疫情期间急性UC就诊量下降16.4%,急性CD下降8.7%。
  • 内镜检查绝对缺口最大,减少17544例(35.2%)。
  • 急性UC的28天急诊再入院率14.1% vs 13.4%(P=0.012)。

核心结论

  • 社区中可能存在大量未治疗的IBD负担,若护理未获优先安排,IBD患者可能经历临床损害或生活质量持续下降。

研究设计与样本

  • 全国性观察性研究,使用英格兰2015至2020年行政数据,比较2015年1月1日至2020年1月31日(疫情前)与2020年2月1日至2021年1月31日(疫情期间)收治的队列。
  • 采用自回归积分滑动平均预测模型估算2020年2月至2021年1月的反事实IBD住院与操作量。

主要发现

  • 急性溃疡性结肠炎(UC)就诊量下降16.4%,急性克罗恩病(CD)下降8.7%。
  • 同次发作合并新冠的患病率低:急性UC为391/16494(2.4%),急性CD为349/15613(2.2%)。
  • 30天死亡率无显著差异。
  • 急性IBD住院中位住院时长缩短1天(P < 0.0001)。
  • 急性UC的28天急诊再入院率更高(14.1% vs 13.4%,P = 0.012)。

关键数值与推荐

  • 2020年2月至2021年1月与反事实估计相比,所有IBD操作和检查量均下降。
  • 绝对缺口最大的是内镜(减少17544例操作,降幅35.2%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inflammatory bowel disease (IBD) services have been particularly affected by the Covid-19 pandemic. Delays in referral to secondary care and access to investigations and surgery have been exacerbated. AIMS: To investigate the use of and outcomes for emergency IBD care during the Covid-19 pandemic. METHODS: Nationwide observational study using administrative data for England (2015-2020) comparing cohorts admitted from 1 January 2015, to 31 January 2020 (pre-pandemic) and from 1 February 2020, to 31 January 2021 (pandemic). Autoregressive integrated moving average forecast models were run to estimate the counterfactual IBD admissions and procedures for February 2020 to January 2021. RESULTS: Large decreases in attendances to hospital for emergency treatment were observed for both acute ulcerative colitis (UC, 16.4%) and acute Crohn's disease (CD, 8.7%). The prevalence of concomitant Covid-19 during the same episode was low [391/16 494 (2.4%) and 349/15 613 (2.2%), respectively]. No significant difference in 30-day mortality was observed. A shorter median length of stay by 1 day for acute IBD admissions was observed (P < 0.0001). A higher rate of emergency readmission within 28 days for acute UC was observed (14.1% vs 13.4%, P = 0.012). All IBD procedures and investigations showed decreases in volume from February 2020 to January 2021 compared with counterfactual estimates. The largest absolute deficit was in endoscopy (17 544 fewer procedures, 35.2% reduction). CONCLUSION: There is likely a significant burden of untreated IBD in the community. Patients with IBD may experience clinical harm or protracted decreases in quality of life if care is not prioritised.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Deputy M, Sahnan K, Worley G, et al. The use of, and outcomes for, inflammatory bowel disease services during the Covid-19 pandemic: a nationwide observational study. Aliment Pharmacol Ther. 2022. PMID: 35132663. doi:10.1111/apt.16800

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。